These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 19479600

  • 1. Hyperthermia and irradiation of head and neck squamous cancer cells causes migratory profile changes of tumour infiltrating lymphocytes.
    Schmidtner J, Distel LV, Ott OJ, Nkenke E, Sprung CN, Fietkau R, Lubgan D.
    Int J Hyperthermia; 2009 Aug; 25(5):347-54. PubMed ID: 19479600
    [Abstract] [Full Text] [Related]

  • 2. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors.
    Mao C, Wang S, Jiang Q, Tong J, Ma J, Yang M, Xu X, Qiu G, Shao Q, Li L, Xu H.
    Onkologie; 2008 May; 31(5):243-8. PubMed ID: 18497513
    [Abstract] [Full Text] [Related]

  • 3. Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.
    Albers AE, Ferris RL, Kim GG, Chikamatsu K, DeLeo AB, Whiteside TL.
    Cancer Immunol Immunother; 2005 Nov; 54(11):1072-81. PubMed ID: 15959774
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
    Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E.
    Clin Cancer Res; 2006 Jan 15; 12(2):465-72. PubMed ID: 16428488
    [Abstract] [Full Text] [Related]

  • 5. The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma.
    Salter J, Maclennan KA, Moore J, Dadian G, Riches PG, Gore ME.
    J Pathol; 1995 Jun 15; 176(2):167-73. PubMed ID: 7636627
    [Abstract] [Full Text] [Related]

  • 6. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity.
    Green VL, Michno A, Stafford ND, Greenman J.
    Cancer Immunol Immunother; 2013 May 15; 62(5):863-73. PubMed ID: 23359088
    [Abstract] [Full Text] [Related]

  • 7. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma.
    Grabenbauer GG, Lahmer G, Distel L, Niedobitek G.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3355-60. PubMed ID: 16740757
    [Abstract] [Full Text] [Related]

  • 8. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion.
    Qin XJ, Shi HZ, Deng JM, Liang QL, Jiang J, Ye ZJ.
    Clin Cancer Res; 2009 Apr 01; 15(7):2231-7. PubMed ID: 19318474
    [Abstract] [Full Text] [Related]

  • 9. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
    Maruyama T, Kono K, Izawa S, Mizukami Y, Kawaguchi Y, Mimura K, Watanabe M, Fujii H.
    Dis Esophagus; 2010 Jul 01; 23(5):422-9. PubMed ID: 20002703
    [Abstract] [Full Text] [Related]

  • 10. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.
    Battaglia A, Buzzonetti A, Baranello C, Ferrandina G, Martinelli E, Fanfani F, Scambia G, Fattorossi A.
    Cancer Immunol Immunother; 2009 Sep 01; 58(9):1363-73. PubMed ID: 19172271
    [Abstract] [Full Text] [Related]

  • 11. CCL22 is involved in the recruitment of CD4+CD25 high T cells into tuberculous pleural effusions.
    Wu C, Zhou Q, Qin XJ, Qin SM, Shi HZ.
    Respirology; 2010 Apr 01; 15(3):522-9. PubMed ID: 20337996
    [Abstract] [Full Text] [Related]

  • 12. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
    Kerrebijn JD, Simons PJ, Balm AJ, Tas M, Knegt PP, de Vries N, Tan IB, Drexhage HA.
    Head Neck; 1996 Apr 01; 18(4):335-42. PubMed ID: 8780944
    [Abstract] [Full Text] [Related]

  • 13. Epidermoid carcinoma-cell culture supernatant's inhibition of monocyte chemotaxis: evidence for a tumour-mediated effect.
    Güngör A, Yetgin S, Ustacelebi S, Sozeri B.
    J Otolaryngol; 1994 Aug 01; 23(4):229-33. PubMed ID: 7996619
    [Abstract] [Full Text] [Related]

  • 14. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
    Mizukami Y, Kono K, Kawaguchi Y, Akaike H, Kamimura K, Sugai H, Fujii H.
    Int J Cancer; 2008 May 15; 122(10):2286-93. PubMed ID: 18224687
    [Abstract] [Full Text] [Related]

  • 15. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.
    Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, Zou W.
    Cancer Res; 2007 Sep 15; 67(18):8900-5. PubMed ID: 17875732
    [Abstract] [Full Text] [Related]

  • 16. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
    Bergs JW, Haveman J, Ten Cate R, Medema JP, Franken NA, Van Bree C.
    Oncol Rep; 2007 Jul 15; 18(1):219-26. PubMed ID: 17549371
    [Abstract] [Full Text] [Related]

  • 17. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.
    Surgery; 2009 Jun 15; 145(6):663-74. PubMed ID: 19486771
    [Abstract] [Full Text] [Related]

  • 18. Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.
    Lang S, Tiwari S, Andratschke M, Loehr I, Lauffer L, Bergmann C, Mack B, Lebeau A, Moosmann A, Whiteside TL, Zeidler R.
    Cancer Immunol Immunother; 2007 Oct 15; 56(10):1645-52. PubMed ID: 17387473
    [Abstract] [Full Text] [Related]

  • 19. Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.
    Schuetz F, Ehlert K, Ge Y, Schneeweiss A, Rom J, Inzkirweli N, Sohn C, Schirrmacher V, Beckhove P.
    Cancer Immunol Immunother; 2009 Jun 15; 58(6):887-900. PubMed ID: 18998129
    [Abstract] [Full Text] [Related]

  • 20. Antigen-specific suppression by induced CD4+CD25high regulatory T cells in kidney recipients.
    Wang Z, Fu XY, Shi BY, Qian YY, Xiao L, Bai HW.
    Transplant Proc; 2009 Jun 15; 41(5):1574-6. PubMed ID: 19545682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.